S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
10 Best Airline Stocks to Buy
The Real Problem With "Made in America" Lithium (Ad)
Stock market today: Global shares trade mixed following technology selloff on Wall Street
What is a Growth Stock Mutual Fund?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Campbell Soup Company Leads Staples Stocks Into The Buy Zone
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
10 Best Airline Stocks to Buy
The Real Problem With "Made in America" Lithium (Ad)
Stock market today: Global shares trade mixed following technology selloff on Wall Street
What is a Growth Stock Mutual Fund?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Campbell Soup Company Leads Staples Stocks Into The Buy Zone
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
10 Best Airline Stocks to Buy
The Real Problem With "Made in America" Lithium (Ad)
Stock market today: Global shares trade mixed following technology selloff on Wall Street
What is a Growth Stock Mutual Fund?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Campbell Soup Company Leads Staples Stocks Into The Buy Zone
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
10 Best Airline Stocks to Buy
The Real Problem With "Made in America" Lithium (Ad)
Stock market today: Global shares trade mixed following technology selloff on Wall Street
What is a Growth Stock Mutual Fund?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Graphite Shortage Could Derail the $7 Trillion EV Transition (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Campbell Soup Company Leads Staples Stocks Into The Buy Zone
NASDAQ:CTSO

Cytosorbents (CTSO) Price Target & Analyst Ratings

$3.31
-0.03 (-0.90%)
(As of 06/7/2023 ET)
Compare
Today's Range
$3.20
$3.41
50-Day Range
$2.37
$3.58
52-Week Range
$1.03
$4.59
Volume
52,809 shs
Average Volume
57,453 shs
Market Capitalization
$145.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Cytosorbents Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$5.50
66.16% Upside
High Prediction$5.50
Average Prediction$5.50
Low Prediction$5.50
TypeCurrent
6/8/22 to 6/8/23
1 Month Ago
5/9/22 to 5/9/23
3 Months Ago
3/10/22 to 3/10/23
1 Year Ago
6/8/21 to 6/8/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.50$5.50$5.75$9.67
Predicted Upside66.16% Upside61.76% Upside92.09% Upside64.29% Upside
Get Cytosorbents Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.


CTSO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTSO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cytosorbents Stock vs. The Competition

TypeCytosorbentsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyBuyHold
Predicted Upside66.16% Upside1,238.86% Upside228.69% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/10/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$5.50+61.76%
(Data available from 6/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CTSO Price Target - Frequently Asked Questions

What is Cytosorbents's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 1 buy rating for CTSO. The average twelve-month price prediction for Cytosorbents is $5.50 with a high price target of $5.50 and a low price target of $5.50. Learn more on CTSO's analyst rating history.

Do Wall Street analysts like Cytosorbents more than its competitors?

Analysts like Cytosorbents more than other Medical companies. The consensus rating score for Cytosorbents is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how CTSO compares to other companies.

Does Cytosorbents's stock price have much upside?

According to analysts, Cytosorbents's stock has a predicted upside of 61.76% based on their 12-month price targets.

What analysts cover Cytosorbents?

Cytosorbents has been rated by HC Wainwright in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CTSO) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -